Where does Millennium Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Millennium Pharmaceuticals, Inc. ranks #2,949 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Millennium Pharmaceuticals, Inc. hold?

Millennium Pharmaceuticals, Inc. holds 129 US utility patents granted between 2015 and 2025, spanning 22 technology areas.

What is Millennium Pharmaceuticals, Inc.'s Innovation Score?

Millennium Pharmaceuticals, Inc. has an Innovation Score of 46.3 out of 100 (top 21% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Millennium Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Millennium Pharmaceuticals, Inc.'s recent grant velocity is -66% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Millennium Pharmaceuticals, Inc.'s patents?

Millennium Pharmaceuticals, Inc.'s patents average 16.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Millennium Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Millennium Pharmaceuticals, Inc.

Q: What technology areas does Millennium Pharmaceuticals, Inc. focus on?

Millennium Pharmaceuticals, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 118 patents. Grants appear in 22 CPC subclasses total.

USPTO PatentsView assignee record - 129 granted patents across 22 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Millennium ranks #2,949 of 49,997 tracked US assignees by granted-patent volume, with 129 patents across 22 technology areas.

#2,949
of 49,997 US assignees by volume: Top 21%
by Innovation Score (46.3/100): 16.3
avg claims per patent: -66%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2949 · US Corporation #2,949 · 129 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 129 grants
TOP-DECILE #2,949/49,997
PHOTO-FINISH Equifax
CPC-FOCUS A61P · 22 areas
INNOV-PAR 46.3/100
CLAIMS-RICH 16.3 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -66% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Equifax Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
AEye · near

46
Avidity Biosciences · near

46
Constellium Issoire · near

46
Gripple · near

46
Millennium Pharmaceu… · this assignee

46
3D Lighting… · lowest

7

What this shows Millennium's Innovation Score is 46.3/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Millennium's grants concentrate

Millennium Pharmaceuticals, Inc. is a focused PatentsView assignee: 22 CPC subclasses with 91.5% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (26 grants) versus a trough of 3 in 2022. By volume, Millennium sits between Equifax Inc. and Swagelok Company.

Millennium's three-year grant acceleration

From 2019–2021 to 2022–2024, Millennium Pharmaceuticals, Inc. moved from 30 to 14 grants (0.47x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,767. See the growth leaderboard.

Equifax

129
First Data

129
Lenovo Innovation…

129
Line Plus

129
Nano and Advanced…

129
Omega

129
Omnissa

129
Swagelok

129
Millennium Pharma… ◀

129

What this shows Millennium holds 129 patents at rank #2,949, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Millennium

By rank, the assignees closest to #2,949 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Millennium's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Millennium, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (46 here).

AEye, Inc. 46 Gripple Limited 46 Avidity Biosciences, Inc. 46 Constellium Issoire 46

Similar claim depth

Nearest assignees by average claims per patent (16.3 here).

University of Manitoba 16.3 avg Etak Systems, LLC 16.3 avg Therma-stor LLC 16.3 avg HL Klemove Corp. 16.3 avg

Millennium's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 21% higher than 79% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Millennium Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	24	18.6%
2016	14	10.9%
2017	26	20.2%
2018	18	14.0%
2019	12	9.3%
2020	11	8.5%
2021	7	5.4%
2022	3	2.3%
2023	4	3.1%
2024	7	5.4%
2025partial year	3	2.3%

Which technologies does Millennium Pharmaceuticals, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 118

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 89

C07D - Heterocyclic Compounds 66

C07K - Peptides 30

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 16

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 14

C07C - Acyclic OR Carbocyclic Compounds 11

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 10

Y02A - Technologies FOR Adaptation TO Climate Change 6

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 5

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 4

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 3

F04B - Positive-displacement Machines FOR LIQUIDS; Pumps 3

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 3

Top 15 of 22 technology areas

Where it ranks

Overall rank by patents

#2,949

of 49,997 tracked assignees

Innovation Score

46.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Millennium Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Millennium Pharmaceuticals, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 91.5% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #2,949 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Millennium Pharmaceuticals, Inc. against Equifax Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.